SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
2 hedge funds and large institutions have $2.91M invested in SAVIENT PHARMACEUTICALS INC in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
295% more capital invested
Capital invested by funds: $737K → $2.91M (+$2.17M)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Frontier Investment Management
Dallas,
Texas
|
+$2.21M |
Top Sellers
SVNT Hedge Fund Activity: Q1 2017 in Review
2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q1 2017, worth a combined $2.91M — up 295% from $737K a quarter earlier.
Fund positioning in SVNT was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Frontier Investment Management, adding an estimated $2.21M.
- 2 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $2.91M of SAVIENT PHARMACEUTICALS INC stock for Q1 2017, up 295% quarter-over-quarter.
- 0 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q1 2017 and 0 closed out.
- The largest SAVIENT PHARMACEUTICALS INC buyer in Q1 2017 was Frontier Investment Management, an estimated $2.21M added.
Based on aggregated 13F filings for Q1 2017.